These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28440303)

  • 1. HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Lee MH; Hsiao TI; Subramaniam SR; Le AK; Vu VD; Trinh HN; Zhang J; Jin M; Wong VW; Wong GL; Nguyen MH
    Am J Gastroenterol; 2017 Jul; 112(7):1111-1119. PubMed ID: 28440303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
    Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
    Reid AE; Koziel MJ; Aiza I; Jeffers L; Reddy R; Schiff E; Lau JY; Dienstag JL; Liang TJ
    Am J Gastroenterol; 1999 Jun; 94(6):1619-26. PubMed ID: 10364034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.
    Bruno S; Crosignani A; Maisonneuve P; Rossi S; Silini E; Mondelli MU
    Hepatology; 2007 Nov; 46(5):1350-6. PubMed ID: 17680653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
    Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
    Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus genotype 3 was associated with the development of hepatocellular carcinoma in Korea.
    Lee SS; Kim CY; Kim BR; Cha RR; Kim WS; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
    J Viral Hepat; 2019 Apr; 26(4):459-465. PubMed ID: 30516858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of hepatitis C virus genotypes and viremia levels with development of hepatocellular carcinoma among Japanese.
    Tanaka K; Hirohata T
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):238-48. PubMed ID: 9778916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
    Stankovic-Djordjevic D; Djordjevic N; Tasic G; Dinic M; Karanikolic A; Pesic M
    J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study.
    Hatzakis A; Katsoulidou A; Kaklamani E; Touloumi G; Koumantaki Y; Tassopoulos NC; Karvountzis G; Gioustozi A; Hadziyannis S; Trichopoulos D
    Int J Cancer; 1996 Sep; 68(1):51-3. PubMed ID: 8895540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
    Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
    El-Serag HB; Kanwal F; Richardson P; Kramer J
    Hepatology; 2016 Jul; 64(1):130-7. PubMed ID: 26946190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.
    Raimondi S; Bruno S; Mondelli MU; Maisonneuve P
    J Hepatol; 2009 Jun; 50(6):1142-54. PubMed ID: 19395111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
    Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
    Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
    Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.
    Silini E; Bottelli R; Asti M; Bruno S; Candusso ME; Brambilla S; Bono F; Iamoni G; Tinelli C; Mondelli MU; Ideo G
    Gastroenterology; 1996 Jul; 111(1):199-205. PubMed ID: 8698200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
    Nkontchou G; Ziol M; Aout M; Lhabadie M; Baazia Y; Mahmoudi A; Roulot D; Ganne-Carrie N; Grando-Lemaire V; Trinchet JC; Gordien E; Vicaut E; Baghad I; Beaugrand M
    J Viral Hepat; 2011 Oct; 18(10):e516-22. PubMed ID: 21914071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
    J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan.
    Tanaka H; Tsukuma H; Yamano H; Okubo Y; Inoue A; Kasahara A; Hayashi N
    J Epidemiol; 1998 Oct; 8(4):244-9. PubMed ID: 9816816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.